Vanguard Group
ONCR

Vanguard Group’s Oncorus, Inc. ONCR Stock Holding History

Vanguard Group’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-475,345
Closed -$164K – 4587
2023
Q1 		$164K Sell
475,345
-20,568
-4% -$7.68K ﹤0.01% 4345
2022
Q4 		$126K Sell
495,913
-401
-0.1% -$228 ﹤0.01% 4367
2022
Q3 		$422K Sell
496,314
-56,326
-10% -$72.2K ﹤0.01% 4259
2022
Q2 		$696K Sell
552,640
-33,970
-6% -$46.1K ﹤0.01% 4199
2022
Q1 		$1.04M Sell
586,610
-324,240
-36% -$908K ﹤0.01% 4191
2021
Q4 		$4.8M Buy
910,850
+137,894
+18% +$1.07M ﹤0.01% 3636
2021
Q3 		$7.22M Buy
772,956
+109,287
+16% +$1.25M ﹤0.01% 3431
2021
Q2 		$9.16M Buy
663,669
+208,980
+46% +$3.23M ﹤0.01% 3253
2021
Q1 		$6.33M Buy
454,689
+158,441
+53% +$3.28M ﹤0.01% 3402
2020
Q4 		$9.58M Buy
+296,248
New +$6.86M ﹤0.01% 3016

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Vanguard Group's ONCR Position: Q2 2023 in Review

Vanguard Group sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 475,345 shares — an estimated $164K sold.

Vanguard Group first reported a position in ONCR in Q4 2020 and held it in 10 quarters. The position peaked at $9.58M in Q4 2020. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Vanguard Group reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Vanguard Group sold 475,345 Oncorus, Inc. shares in Q2 2023, an estimated $164K.
  • Vanguard Group first reported a position in Oncorus, Inc. in Q4 2020 and held it in 10 quarters.
  • Vanguard Group's Oncorus, Inc. position peaked at $9.58M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Vanguard Group's 13F filing for Q2 2023, filed 14 Aug 2023.